Amsterdam and Boston, July 15, 2019 - The Journal of Alzheimer's Disease (JAD) is pleased to announce a new partnership with the Advanced Continuing Education Association (ACEA) to provide a new series of fully accredited continuing medical education (CME) journal articles. The program, accredited under the ACCME and open to US and Canadian physicians, launches today with 10 landmark articles published in JAD, each with a corresponding CME post-test providing 1.0 AMA PRA Category 1 Credit™.
"We are extremely excited to add CME-accredited content as a service to the Alzheimer's disease (AD) community. Initially, we are featuring 10 of the most recent significant and popular articles published in JAD. These articles have been carefully chosen so that medical professionals with an interest in AD participating in this program can translate clinically relevant, evidence-based diagnostic and therapeutic findings into clinical practice, improving patient care and outcomes," commented George Perry, PhD, Editor-in-Chief, Journal of Alzheimer's Disease, and Chief Scientist of the Brain Health Consortium at the University of Texas at San Antonio.
"ACEA is very pleased to bring the new innovation and research that JAD publishes about consistently to practicing clinicians through a new CME offering. This is exactly the sort of content that physicians need in order to advance the practice of medicine and accelerate further research," ACEA's Head of Strategic Support, Kyle Kahveci, said.
The catalog of currently available CME articles covers a broad range of important topics in AD and is posted on the JAD website at j-alz.com/cme-credits. New articles will be added to the program on an ongoing basis; all of these articles are freely available and thereby accessible by both journal subscribers and non-subscribers. Readers can choose to invest a small fee to gain CME credit after reading an article. Participants who opt to join the ACEA community can receive additional support and access to improve their CME experience at no cost.